Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 27, 2024

Effects of Semaglutide, Empagliflozin and Their Combination on Kidney Sodium Signal From Magnetic Resonance Imaging

Journal of Diabetes and its Complications


Additional Info

Journal of Diabetes and its Complications
The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial
J Diabetes Complicat 2024 Jan 05;38(2)108673, S Gullaksen, L Vernstrøm, SS Sørensen, S Ringgaard, C Laustsen, H Birn, KL Funck, PL Poulsen, E Laugesen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading